Patients should always seek the advice of a doctor or pharmacist in case of adverse events.
If you wish to report an adverse event to ELC Group s.r.o., please find the contact information below:
To contact us about any other issue please call:
Pacienti by meli vždy požádat o radu svého lékare nebo lékárníka v prípade výskytu nežádoucích príhod.
Pokud chcete nahlásit nežádoucí príhodu spolecnosti ELC Group s r.o., prosím využijte kontaktních údaju níže:
Pro záležitosti, které se netýkaji farmakovigilance, kontaktujte prosím recepci:
+420 22 491 0000 nebo naše další pobočky.
Unique two-day training event will deliver expert updates on latest European and South Asian regulatory landscape
Cambridge, UK, 10th January 2013 – ELC GROUP, one of the fastest-growing providers of regulatory affairs consulting services, today announces that it will be hosting a two-day international training seminar from 28th February – 1st March 2013 in Mumbai, India. The unique training event, which will span all aspects of European and South Asian Regulatory systems, follows the success last year of ELC Group’s international regulatory seminar held in Ahmedabad, India.
The two-day seminar will provide a unique opportunity for pharmaceutical industry professionals to review the current international regulatory landscape and interact with experts in the field. The purpose of the course is to provide attendees with a clear and concise understanding of the regulatory environment in both the European Union and South Asia markets (including Vietnam, Indonesia, China and Australia).
The training content will deliver a comprehensive overview of the key regulatory processes and procedures in these major markets, with a specific focus on the following key areas:
Attendance is encouraged from pharmaceutical industry and regulatory affairs professionals, plus business development executives interested in the impact of regulatory strategy on commercial, business and licensing arrangements.